OBERMANNOVÁ, Radka, M. ALSINA, A. CERVANTES, T. LEONG, F. LORDICK, M. NILSSON, N. C. T. VAN GRIEKEN, A. VOGEL and E. C. SMYTH. Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology. AMSTERDAM: Elsevier, 2022, vol. 33, No 10, p. 992-1004. ISSN 0923-7534. Available from: https://dx.doi.org/10.1016/j.annonc.2022.07.003.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Authors OBERMANNOVÁ, Radka (203 Czech Republic, guarantor, belonging to the institution), M. ALSINA, A. CERVANTES, T. LEONG, F. LORDICK, M. NILSSON, N. C. T. VAN GRIEKEN, A. VOGEL and E. C. SMYTH.
Edition Annals of Oncology, AMSTERDAM, Elsevier, 2022, 0923-7534.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 50.500
RIV identification code RIV/00216224:14110/22:00128842
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.annonc.2022.07.003
UT WoS 000938788800003
Keywords in English diagnosis; ESMO Clinical Practice Guideline; follow-up; oesophageal cancer; treatment
Tags 14110811, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/4/2023 08:44.
Abstract
This ESMO Clinical Practice Guideline provides key recommendations for managing oesophageal cancer. • The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. • Algorithms for the management of locoregional and advanced/metastatic disease are provided. • The author group encompasses a multidisciplinary group of experts from different institutions in Europe and Australia. • Recommendations are based on available scientific data and the authors’ collective expert opinion.
PrintDisplayed: 18/7/2024 17:34